FDA Adverse Event Injury Summary report: N

VENTRALEX ST

MDR report key: 8143425 · Received December 7, 2018

Report

Report Number
1213643-2018-04483
Event Type
Injury
Date Received
December 7, 2018
Date of Event
December 16, 2016
Report Date
December 7, 2018
Manufacturer
DAVOL INC., SUB. C.R. BARD, INC.
Product Code
FTL
UDI-DI
00801741031472
PMA / PMN Number
K101928
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
003

Narratives

Additional Manufacturer Narrative · 1

THE CAUSE OF THE PATIENT'S POST-OP COMPLICATIONS CANNOT BE DETERMINED AT THIS TIME. RECURRENCE IS A KNOWN INHERENT RISK OF SURGERY AND IS LISTED IN THE INSTRUCTIONS-FOR-USE A POSSIBLE COMPLICATION. NO MEDICAL RECORDS HAVE BEEN PROVIDED AND NO SAMPLE WAS RETURNED FOR EVALUATION. BASED ON THE LIMITED INFORMATION PROVIDED AT THIS TIME, NO CONCLUSIONS CAN BE MADE. SHOULD ADDITIONAL INFORMATION BE PROVIDED A SUPPLEMENTAL EMDR WILL BE SUBMITTED. NOTE: NO SAMPLE RETURNED.

Description of Event or Problem · 1

THE FOLLOWING WAS ALLEGED BY THE PATIENT'S ATTORNEY: (B)(6) 2016: THE PATIENT UNDERWENT REPAIR OF AN EPIGASTRIC HERNIA WITH IMPLANT OF A BARD/DAVOL VENTRALEX ST MESH, REFERENCE NUMBER 5950007, LOT NUMBER HUZJ1083. ON (B)(6) 2016: THE PATIENT UNDERWENT SURGERY TO REMOVE THE BARD/DAVOL VENTRALEX ST MESH AND REPAIR A RECURRENCE OF PATIENT'S HERNIA DEFECT. DURING THE SURGERY THE PHYSICIAN NOTED THAT "THE PREVIOUS REPAIR ALSO SHOWS EVIDENCE OF RECURRENCE WITH MULTIPLE SMALL HERNIA DEFECTS OVER FOR 3-4CM AREA. THE MESH IS PALPABLE AND IS COMING UP THROUGH THE HERNIA DEFECT." AS ALLEGED BY THE PATIENT'S ATTORNEY, THE PATIENT CONTINUES TO EXPERIENCE COMPLICATIONS RELATED TO THE VENTRALEX ST MESH. SHE CONTINUES TO HAVE PROBLEMS INCLUDING PAIN AND NAUSEA. PATIENT HAS BEEN INJURED. SHE HAS SUSTAINED SEVERE AND PERMANENT PAIN, SUFFERING, ANXIETY, DEPRESSION, DISABILITY, IMPAIRMENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
983051 VENTRALEX ST SURGICAL MESH FTL DAVOL INC., SUB. C.R. BARD, INC. NA HUZJ1083 00801741031472

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention| S